2521:TSE:TSE-Listed Index Fund US Equity (S&P500) Currency Hedge (JPY)

ETF | Others |

Last Closing

USD 1740

Change

+2.50 (+0.14)%

Market Cap

USD 34.00B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
1306:TSE Nomura TOPIX Listed

+35.00 (+1.26%)

USD 23,611.00B
1308:TSE Nikko TOPIX Listed

+37.00 (+1.35%)

USD 11,091.37B
1321:TSE Nomura Nikkei 225 Listed

+750.00 (+1.91%)

USD 11,082.14B
1305:TSE Daiwa TOPIX Listed

+35.00 (+1.25%)

USD 10,799.81B
1330:TSE Nikko Nikkei 225 Listed

+770.00 (+1.96%)

USD 5,423.56B
1320:TSE Daiwa Nikkei 225 Listed

+720.00 (+1.84%)

USD 5,181.88B
1348:TSE MAXIS TOPIX

+35.00 (+1.26%)

USD 3,383.69B
1346:TSE MAXIS Nikkei 225

+760.00 (+1.94%)

USD 2,731.89B
1475:TSE iShares Core TOPIX ETF

+3.40 (+1.24%)

USD 1,877.98B
1591:TSE NEXT FUNDS JPX-Nikkei Index 40..

+365.00 (+1.49%)

USD 1,666.73B

ETFs Containing 2521:TSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.69% 52% F 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.69% 52% F 70% C-
Trailing 12 Months  
Capital Gain 25.86% 77% C+ 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.86% 77% C+ 79% B-
Trailing 5 Years  
Capital Gain 69.92% 56% F 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 69.92% 56% F 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 11.43% N/A N/A 60% D-
Dividend Return 11.43% N/A N/A 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 18.11% N/A N/A 75% C
Risk Adjusted Return 63.11% N/A N/A 77% C+
Market Capitalization 34.00B 64% D 61% D-

Annual Financials (JPY)

Quarterly Financials (JPY)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike